| Name | Title | Contact Details |
|---|
C-TASC provides products and services to support responsible management of clinical trials, clinical surveys, case/control studies, clinical registries, clinical cohort studies and laboratory studies. For over 15 years C-TASC's services group has played nearly every role in studies of all sizes. Our experienced and professional medical and biostatistical staff can provide expertise in complete study design, data collection and management and data analysis. C-TASC's software group has developed, hosted and managed Web-based clinical data management systems for dozens of studies including the recent release of our SaaS product StudyCTMS.com, an end-to-end clinical trials management system (CTMS) including electronic data capture (EDC), integrated SAS, a drag and drop form builder and many other intuitive tools. StudyCTMS.com is an affordable solution for every investigator. Our location is convenient to Washington DC, Maryland, Philadelphia, and Southern New Jersey.
Assembly Biosciences (NASDAQ: ASMB) is a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome. The HBV program is focused on advancing a new class of potent, oral core inhibitors that have the potential to increase cure rates for chronically infected patients. The microbiome program is developing novel oral live microbial biotherapeutic candidates with Assembly`s fully integrated platform, including a robust process for strain identification and selection, GMP banking and production, and targeted delivery to the lower gastrointestinal tract with the GEMICEL® technology. We pride ourselves on creating a culture and work environment that is scientifically driven, ambitious, and collaborative. We encourage diversity of thought that leads to great innovation and are looking to add to our dynamic team great people who are driven to transform the lives of patients. We believe our Microbiome platform represents a best in class approach to developing biopharmaceutical agents from live biotherapeutic products. ABI-M201, our lead program in mildly to moderately active ulcerative colitis (UC), is currently in a phase 1b clinical trial. This program is part of a broader collaboration we established with Allergan in 2017 for gastrointestinal programs such as UC, Crohn`s disease and Irritable Bowel Syndromes with potential total development and commercial milestones of up to $2.8 billion. Our internal pipeline comprises first in class or best in class live microbial biotherapeutic approaches in areas such as oncology, immune mediated and metabolic disorders, and other areas of high medical need. Assembly is headquartered in Carmel, Indiana, while the R&D headquarters is in South San Francisco. The Company also has a microbiome manufacturing facility in Groton, CT, and offices in China.
Cegedim Relationship Management is a Bedminster, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Pharmacyclics is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Sunnyvale, CA. To find more information about Pharmacyclics, please visit www.pcyc.com
Affiliated Sante Group is a Silver Spring, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.